Is the in situ inflammatory reaction an important tool to understand the cellular immune response in American tegumentary leishmaniasis?

British Journal of Dermatology

Volumn 158, Issue 1, 2008, Pages 50-58

  Morgado, F N ^a   Schubach, A ^b   Rosalino, C M V ^b,c   Quintella, L P ^b   Santos, G ^b   Salgueiro, M ^b   Conceicao Silva F ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

American tegumentary leishmaniasis; Cellular immunity; Immunohistochemistry; In situ; Leishmania sp.

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROSIS; SKIN INFLAMMATION; SKIN LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOENZYME TECHNIQUES; INFLAMMATION; LANGERHANS CELLS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; T-LYMPHOCYTE SUBSETS;

EID: 36849059743     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08255.x     Document Type: Article

References (44)

1. de Pita-Pereira D, Alves CR, Souza MB et al. Identification of naturally infected Lutzomyia intermedia and Lutzomyia migonei with Leishmania (Viannia) braziliensis in Rio de Janeiro (Brazil) revealed by a PCR multiplex non-isotopic hybridisation assay. Trans R Soc Trop Med Hyg 2005 99 : 905 13.
2. Pirmez C, Yamamura M, Uyemura K et al. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993 91 : 1390 5.
3. Diaz NL, Arveláez FA, Zerpa O, Tapia FJ. Inducible nitric oxide synthase and cytokine pattern in lesions of patients with American cutaneous leishmaniasis. Clin Exp Dermatol 2006 31 : 114 17.
4. Bos JD, Kapsenberg ML. The skin immune system: progress in cutaneous biology. Immunol Today 1993 14 : 75 8.
5. Spellberg B. The cutaneous citadel: a holistic view of skin and immunity. Life Sci 2000 67 : 477 502.
6. Cristoph T, Muller-Röver S, Audring H et al. The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 2000 142 : 862 73.
7. Zierhut M, Bieber T, Bröcker EB et al. Immunology of the skin and the eye. Immunol Today 1996 17 : 448 50.
8. Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004 4 : 211 22.
9. Ramirez JL, Guevara P. Persistent infections by Leishmania (Viannia) braziliensis. Mem Inst Oswaldo Cruz 1997 92 : 333 8.
10. Bogdan C, Rollinghoff M. How do protozoan parasites survive inside macrophages? Parasitol Today 1999 15 : 22 8.
11. Schubach A, Cuzzi-Maya T, Oliveira AV et al. Leishmanial antigens in the diagnosis of active lesions and ancient scars of American tegumentary leishmaniasis patients. Mem Inst Oswaldo Cruz 2001 96 : 987 96.
12. Belkaid Y, Hoffmann KF, Mendez S et al. The role of interleukin-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 2001 194 : 1497 506.
13. Spath GF, Lye L, Segawa H et al. Persistence without pathology in phosphoglycan-deficient Leishmania major. Science 2003 301 : 1241 3.
14. Aebischer T. Recurrent cutaneous leishmaniasis: a role for persistent parasites? Parasitol Today 1994 10 : 25 8.
15. Stenger S, Donhauser N, Thüring H et al. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 1996 183 : 1501 14.
16. Amato VS, Andrade HF Jr., Duarte MIS. Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment. Acta Trop 2003 85 : 39 49.
17. Mendez S, Reckling SK, Piccirillo CA et al. Role for CD4+ CD25+ regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med 2004 200 : 201 10.
18. Gaze ST, Dutra WO, Lessa M et al. Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population. Scand J Immunol 2006 63 : 70 8.
19. Elhassan AM, Gaafar A, Theander TG. Antigen-presenting cells in human cutaneous leishmaniasis due to Leishmania major. Clin Exp Immunol 1995 99 : 445 53.
20. Koch S, Kohl K, Klein E et al. Skin homing of Langerhans cell precursors: adhesion, chemotaxis, and migration. J Allergy Clin Immunol 2006 117 : 163 8.
21. Esterre P, Dedet JP, Frenay C et al. Cell populations in the lesion of human cutaneous leishmaniasis: a light microscopical, immunohistochemical and ultrastructural study. Virchows Arch A Pathol Anat Histopathol 1992 421 : 239 47.
22. Lima HC, Vasconcelos AW, David JR, Lerner EA. American cutaneous leishmaniasis: in situ characterization of the cellular immune response with time. Am J Trop Med Hyg 1994 50 : 743 7.
23. Diaz NL, Zerpa O, Ponce LV et al. Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterization of the lesion. Exp Dermatol 2002 11 : 34 41.
24. Madeira MF, Schubach A, Schubach TM et al. Mixed infection with Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi in a naturally infected dog from Rio de Janeiro, Brazil. Trans R Soc Trop Med Hyg 2006 100 : 442 5.
25. Magalhães AV, Moraes MAP, Raick AN et al. Histopatologia da leishmaniose tegumentar por Leishmania braziliensis braziliensis. 1. Padrões histopatológicos e estudo evolutivo das lesões. Rev Inst Med Trop Sao Paulo 1986 28 : 253 62.
26. Bourreau E, Gardon J, Pradinaud R et al. Th2 responses predominate during the early phases of infection in patients with localized cutaneous leishmaniasis and precede the development of Th1 responses. Infect Immun 2003 71 : 2244 6.
27. Da-Cruz AM, Bertho AL, Oliveira-Neto MP, Coutinho SG. Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions. Br J Dermatol 2005 153 : 537 43.
28. Bradonisio O, Panaro MA, Sisto M et al. Nitric oxide production by Leishmania-infected macrophages and modulation by cytokines and prostaglandins. Parassitologia 2001 43 : 1 6.
29. Perez LE, Chandrasekar B, Saldarriaga OA et al. Reduced nitric oxide synthase 2 (NOS2) promoter activity in the Syrian hamster renders the animal functionally deficient in NOS2 activity and unable to control an intracellular pathogen. J Immunol 2006 176 : 5519 28.
30. Lang T, Hellio R, Kaye PM, Antoine JC. Leishmania donovani-infected macrophages: characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation. J Cell Sci 1994 107 : 2137 50.
31. De Souza-Leão S, Lang T, Prina E et al. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J Cell Sci 1995 108 : 3219 31.
32. Orteu CH, Poulter LW, Rustin MHA et al. The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation. J Immunol 1998 161 : 1619 29.
33. Fadok VA, Bratton DL, Konowal A et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998 101 : 890 8.
34. Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 2005 4 : 281 6.
35. Conceição-Silva F, Hahne M, Schröter M et al. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur J Immunol 1998 28 : 237 45.
36. Conceição-Silva F, Perlaza BL, Louis JÁ, Romero P. Leishmania major infection in mice primes for specific major histocompatibility complex class I-restricted CD8+ cytotoxic T cell responses. Eur J Immunol 1994 24 : 2813 17.
37. Da-Cruz AM, Conceição-Silva F, Bertho AL, Coutinho SG. Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. Infect Immun 1994 62 : 2614 18.
38. Brodskyn CI, Barral A, Boaventura V et al. Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. J Immunol 1997 159 : 4467 73.
39. Machado P, Kanitakis J, Almeida R et al. Evidence of in situ cytotoxicity in American cutaneous leishmaniasis. Eur J Dermatol 2002 12 : 449 51.
40. Isaza DM, Restrepo M, Restrepo R et al. Immunocytochemical and histopathologic characterization of lesions from patients with localized cutaneous leishmaniasis caused by Leishmania panamensis. Am J Trop Med Hyg 1996 55 : 365 9.
41. Lima GMAC, Vallochi AL, Silva UR et al. The role of polymorphonuclear leukocytes in the resistance to cutaneous leishmaniasis. Immunol Lett 1998 64 : 145 51.
42. Taskapan MO, Kumar P. Role of staphylococcal superantigens in atopic dermatitis: from colonization to inflammation. Ann Allergy Asthma Immunol 2000 84 : 3 10.
43. Moll H, Flohé S, Röllinghoff M. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur J Immunol 1995 25 : 693 9.
44. Dien-Nosjan MC, Massacrier C, Homey B et al. Macrophage inflammatory protein 3α is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 2000 192 : 705 17.